
The development of zzso in zzso organ transplant recipients has recently gained increasing zzso Increased awareness of this problem has come from recent data indicating that vascular disease and cancer are the leading causes of death in transplant zzso Despite the realization of this fact, few efforts have been made to thwart deaths due to cancer in transplant zzso However, now that many transplant recipients maintain their organ zzso for decades, the risk for cancer is increasing even more, exposing a need for possible zzso zzso transplant recipients are at a high risk for cancer because the zzso drugs used in their treatment regimen suppress immune zzso against arising cancer zzso Some of these drugs directly impede DNA repair, induce cancer cell zzso and promote tumor zzso In situations where cancer has developed in transplant recipients, one potential action is to reduce their daily zzso In some cases zzso zzso can reduce tumor growth or even result in tumor regression, but the threat of rejection increases zzso Another possible solution is to move toward zzso target of zzso zzso zzso use of which has been zzso demonstrated to have both zzso and potent zzso zzso Clinical studies are presently zzso to test this idea, which could help to alleviate the problem of cancer in transplant zzso In this zzso the topic of cancer in transplant recipients will be zzso as well as new approaches to reduce this increasingly recognized problem in zzso 

